emergencycollab

MALVERN, Pa., Nov. 15, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics (“MC2”) to commercialize Wynzora® Cream (calcipotriene and betamethasone dipropionate) in Canada through […]

MALVERN, Pa., Aug. 7, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) (“Endo” or the “Company”) announced today that it will release its second quarter 2024 financial results on August 27, 2024, prior to market open. […]